IL133752A - Process for Momatazone Foroat - Google Patents
Process for Momatazone ForoatInfo
- Publication number
- IL133752A IL133752A IL13375299A IL13375299A IL133752A IL 133752 A IL133752 A IL 133752A IL 13375299 A IL13375299 A IL 13375299A IL 13375299 A IL13375299 A IL 13375299A IL 133752 A IL133752 A IL 133752A
- Authority
- IL
- Israel
- Prior art keywords
- mometasone
- process according
- reaction
- furoate
- solvent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 23
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 title claims abstract description 19
- 229960002744 mometasone furoate Drugs 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 229960001664 mometasone Drugs 0.000 claims abstract description 9
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims abstract description 9
- OFTKFKYVSBNYEC-UHFFFAOYSA-N 2-furoyl chloride Chemical compound ClC(=O)C1=CC=CO1 OFTKFKYVSBNYEC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000003512 tertiary amines Chemical class 0.000 claims abstract description 5
- 239000012442 inert solvent Substances 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- 150000002085 enols Chemical class 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000003610 charcoal Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000004821 distillation Methods 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- -1 trialkylsilyl ether Chemical compound 0.000 description 2
- MBKAANDQMJJTRM-VTZACXCQSA-N (8S,10S,13S,14S,17R)-17-(2-chloroacetyl)-17-hydroxy-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one Chemical compound C([C@H]12)CC3=CC(=O)C=C[C@]3(C)C1=CC[C@@]1(C)[C@H]2CC(C)[C@]1(O)C(=O)CCl MBKAANDQMJJTRM-VTZACXCQSA-N 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical group OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT102343A PT102343B (pt) | 1999-08-02 | 1999-08-02 | Processo para a preparacao de furoato mometasona |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL133752A0 IL133752A0 (en) | 2001-04-30 |
| IL133752A true IL133752A (en) | 2004-02-19 |
Family
ID=20085881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13375299A IL133752A (en) | 1999-08-02 | 1999-12-27 | Process for Momatazone Foroat |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6177560B1 (zh) |
| EP (1) | EP1074558B1 (zh) |
| JP (1) | JP3746174B2 (zh) |
| KR (1) | KR100640066B1 (zh) |
| CN (1) | CN1149222C (zh) |
| AT (1) | ATE229970T1 (zh) |
| AU (1) | AU765592B2 (zh) |
| CA (1) | CA2295455C (zh) |
| DE (1) | DE69904585T2 (zh) |
| DK (1) | DK1074558T3 (zh) |
| ES (1) | ES2189354T3 (zh) |
| HR (1) | HRP990341B1 (zh) |
| HU (1) | HU227494B1 (zh) |
| IL (1) | IL133752A (zh) |
| NO (1) | NO321154B1 (zh) |
| NZ (1) | NZ500555A (zh) |
| PL (1) | PL191103B1 (zh) |
| PT (1) | PT102343B (zh) |
| RU (1) | RU2208616C2 (zh) |
| SI (1) | SI1074558T1 (zh) |
| UA (1) | UA60333C2 (zh) |
| ZA (1) | ZA996758B (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
| EP1790754A1 (de) * | 2005-11-24 | 2007-05-30 | Siemens Aktiengesellschaft | Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase |
| US8021742B2 (en) * | 2006-12-15 | 2011-09-20 | Siemens Energy, Inc. | Impact resistant thermal barrier coating system |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| TWI695723B (zh) | 2009-05-29 | 2020-06-11 | 美商沛爾醫療股份有限公司 | 用於經由呼吸道輸送活性劑的組成物以及相關方法與系統 |
| PT105139B (pt) * | 2010-06-01 | 2013-01-29 | Hovione Farmaciencia S A | Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos |
| US20140275517A1 (en) | 2013-03-15 | 2014-09-18 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
| JP2016519160A (ja) | 2013-05-22 | 2016-06-30 | パール セラピューティクス，インコーポレイテッド | ３つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム |
| CN105481933B (zh) * | 2015-12-25 | 2017-09-19 | 山东京卫制药有限公司 | 一种合成糠酸莫米松的方法 |
| CN105566437B (zh) * | 2015-12-30 | 2018-07-20 | 山东京卫制药有限公司 | 一种8dm衍生物及利用其合成糠酸莫米松的方法 |
| CN107266518B (zh) * | 2016-04-08 | 2021-03-30 | 天津金耀集团有限公司 | 一种糠酸莫米松晶型及其制备方法 |
| KR20240042438A (ko) | 2021-07-09 | 2024-04-02 | 아스트라제네카 파마수티컬스 엘피 | 에어로졸 약물 전달을 위한 조성물, 방법 및 시스템 |
| WO2023119093A1 (en) | 2021-12-20 | 2023-06-29 | Astrazeneca Ab | Compositions, methods and systems for aerosol drug delivery |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0057401B1 (en) * | 1981-02-02 | 1984-08-01 | Schering Corporation | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them |
| IL127782A (en) * | 1996-06-28 | 2004-06-20 | Schering Corp | Process for making 17 asters of 9a, 21 - Dihalo - Pargan - 11b, 17a Diyol - 20 ounces |
| US5886200A (en) * | 1996-07-01 | 1999-03-23 | Schering Corporation | Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones |
-
1999
- 1999-08-02 PT PT102343A patent/PT102343B/pt unknown
- 1999-08-02 NZ NZ500555A patent/NZ500555A/xx not_active IP Right Cessation
- 1999-10-21 HU HU9903747A patent/HU227494B1/hu unknown
- 1999-10-22 AU AU56024/99A patent/AU765592B2/en not_active Expired
- 1999-10-25 DE DE69904585T patent/DE69904585T2/de not_active Expired - Lifetime
- 1999-10-25 SI SI9930173T patent/SI1074558T1/xx unknown
- 1999-10-25 DK DK99308380T patent/DK1074558T3/da active
- 1999-10-25 EP EP99308380A patent/EP1074558B1/en not_active Expired - Lifetime
- 1999-10-25 AT AT99308380T patent/ATE229970T1/de active
- 1999-10-25 ES ES99308380T patent/ES2189354T3/es not_active Expired - Lifetime
- 1999-10-26 NO NO19995225A patent/NO321154B1/no not_active IP Right Cessation
- 1999-10-27 ZA ZA9906758A patent/ZA996758B/xx unknown
- 1999-11-03 KR KR1019990048285A patent/KR100640066B1/ko active IP Right Grant
- 1999-11-03 RU RU99123183/04A patent/RU2208616C2/ru active
- 1999-11-04 UA UA99116069A patent/UA60333C2/uk unknown
- 1999-11-05 JP JP31523699A patent/JP3746174B2/ja not_active Expired - Lifetime
- 1999-11-05 HR HR990341A patent/HRP990341B1/xx not_active IP Right Cessation
- 1999-11-05 PL PL336452A patent/PL191103B1/pl unknown
- 1999-11-26 CN CNB991243803A patent/CN1149222C/zh not_active Expired - Lifetime
- 1999-12-27 IL IL13375299A patent/IL133752A/en not_active IP Right Cessation
- 1999-12-29 US US09/476,004 patent/US6177560B1/en not_active Expired - Lifetime
-
2000
- 2000-01-14 CA CA002295455A patent/CA2295455C/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR1449628A (fr) | Procédé de préparation d'indoles polynucléaires désacylés, notamment d'esters de la série de la désacétyl-vincaleucoblastine et de la désacétyl-vincristine | |
| CA2295455C (en) | Process for the preparation of mometasone furoate | |
| HU221980B1 (hu) | Eljárás diacerein előállítására és új acilezett aloin intermedier | |
| FR2675145A1 (fr) | Procede de preparation du ginkgolide b a partir du ginkgolide c. | |
| EP2262823B1 (en) | Process for the preparation of pregnane derivatives | |
| IE53323B1 (en) | Process for the preparation of isosorbide-2-nitrate | |
| US5401858A (en) | Preparation of quinic acid derivatives | |
| JP2000503666A (ja) | Ｍａｐｐｉａ ｆｏｅｔｉｄａから単離したカンプトセシン―骨格化合物および新規な医薬ならびに治療薬のためのシントンとしてのその使用 | |
| EP1230252B1 (fr) | Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique | |
| MXPA00000670A (es) | Proceso para la preparacion de furoato de mometasona | |
| US2705232A (en) | Ternorcholanylthiazoles | |
| US4277409A (en) | Preparation of 9α-fluoro-16α-methyl-21-acetoxy-Δ1,4 -pregnadiene-11β-ol-3,20-dione | |
| EP0006355A1 (en) | Mixed anhydride steroid intermediate and process for preparing steroid intermediates | |
| JPH069709A (ja) | シクロデキストリン誘導体及びその製造方法 | |
| FR2481279A1 (fr) | Esters hydrosolubles de steroido-oxazoles et compositions pharmaceutiques les contenant | |
| JPH023798B2 (zh) | ||
| CN109575096B (zh) | 一种制备16a-羟基泼尼松龙产品的新方法 | |
| EP2331549A1 (fr) | Procede de preparation du 1,6:2,3-dianhydro-beta-d-mannopyranose | |
| JPH10503509A (ja) | ８−フルオロ−アントラサイクリン類、それらの調整法及びそれらを含む薬学的組成品 | |
| CN109651475B (zh) | 一种制备16a-羟基泼尼松龙的新方法 | |
| JPS60181096A (ja) | 胆汁酸の精製方法 | |
| WO2014071983A1 (en) | Process for making the 17-triflate intermediate of abiraterone-3-acetate | |
| WO2018102369A1 (en) | Methods for onapristone synthesis dehydration and deprotection | |
| CS236228B1 (cs) | Způsob výroby 3<x-acetoxyderivátů žlučových kyselin | |
| JPH07252303A (ja) | シクロデキストリン誘導体およびその製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |